SCHEMBL17126864

SCHEMBL17126864

CCOCCSC(C(=O)c1ccc(Oc2ccc3cc(OC)c(OC)cc3c2)cc1)C(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SCN9A Q15858 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ MAPT P10636 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ AKR1C3 P42330 3/20 0.32
▸ AKR1C2 P52895 3/20 0.32
▸ AKR1C1 Q04828 1/20 0.32
▸ PTGS1 P23219 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ XDH P47989 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17126862 0.93 AKR1C3 (0.39) SCN9AHPGDSMN1; SMN2KDM4ELMNA
SCHEMBL17126856 0.90 SMN1; SMN2 (0.33) SCN9ASMN1; SMN2MAPTLMNAMEN1
SCHEMBL17127353 0.89 HIF1A (0.40) SMN1; SMN2KDM4ELMNAAKR1C3AKR1C2
SCHEMBL17127022 0.89 PTGS2 (0.38) SCN9ASMN1; SMN2KDM4ELMNANPC1
SCHEMBL17126973 0.87 SMN1; SMN2 (0.43) HPGDSMN1; SMN2MAPTKDM4ELMNA
SCHEMBL17126975 0.87 TTR (0.39) HPGDSMN1; SMN2MAPTLMNANPC1
SCHEMBL17126863 0.87 ACACB (0.37) SMN1; SMN2MAPTLMNAMEN1KMT2A
SCHEMBL17126983 0.85 SMN1; SMN2 (0.36) HPGDSMN1; SMN2MAPTKDM4ELMNA
SCHEMBL17127350 0.84 HIF1A (0.39) SMN1; SMN2MAPTLMNAAKR1C3AKR1C2
SCHEMBL15935680 0.84 SMN1; SMN2 (0.46) HPGDSMN1; SMN2MAPTKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2015-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE TERB1, ACTR5, ADPRS SCN9A 1243/4885HPGD 2453/4885SMN1; SMN2 2675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback